Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Industry
>>
Conmana (Icotinib) injection launched in China for lung cancer
>> article
Conmana (Icotinib) injection launched in China for lung cancer
Editor:bianch Clicks:
0
Date:2011-8-17 16:20:44
Keyword:
Conmana Icotinib NSCLC
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
KaiMeiNa sales reached 915 MN Yuan in 2015
Lung cancer drug Conmana sold well in&nb...
Irassa certified as frontier NSCLC drug
Phase III trials of Icotinib finished fo...
Phase 3 trial of Stimuvax in Asian ...
Icotinib enters into phase Ⅲ trial for&n...
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
